DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 089577
NDA 089577 describes A-HYDROCORT, which is a drug marketed by Abbott and Hospira and is included in ten NDAs. Additional details are available on the A-HYDROCORT profile page.
The generic ingredient in A-HYDROCORT is hydrocortisone sodium succinate. There are sixty-four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydrocortisone sodium succinate profile page.
The generic ingredient in A-HYDROCORT is hydrocortisone sodium succinate. There are sixty-four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydrocortisone sodium succinate profile page.
Summary for 089577
| Tradename: | A-HYDROCORT |
| Applicant: | Abbott |
| Ingredient: | hydrocortisone sodium succinate |
| Patents: | 0 |
| Therapeutic Class: | Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) Inflammatory Bowel Disease Agents |
| Formulation / Manufacturing: | see details |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 100MG BASE/VIAL | ||||
| Approval Date: | Apr 11, 1989 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
